Author:
Kocic Ivana,Homsek Irena,Dacevic Mirjana,Parojcic Jelena,Miljkovic Branislava
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference44 articles.
1. Green WL. New questions regarding bioequivalence of levothyroxine preparations: a clinician’s response. AAPS J. 2005;7:E54–8.
2. Hennessey JV. Levothyroxine dosage and the limitations of current bioequivalence standards. Nat Clin Pract Endocrinol Metab. 2006;2:474–5.
3. European Medicines Agency. Guideline on the investigation of bioequivalence. CPMP/EWP/QWP/1401/98. Rev.1, January 2010. London: European Medicines Agency; 2010.
4. Bolton S. Bioequivalence studies for levothyroxine. AAPS J. 2005;7:E47–53.
5. FDA. Guidance for industry: levothyroxine sodium tablets—in vivo pharmacokinetic and bioavailability studies and in vitro dissolution testing. U.S. Department of Health and Human Services, CDER/FDA; 2000.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献